Low levels of emotional awareness predict a better response to dermatological treatment in patients with psoriasis

Dermatology

Volumn 212, Issue 2, 2006, Pages 128-136

  Consoli, Silla M ^a   Rolhion, Sophie ^b   Martin, Caroline ^b   Ruel, Karine ^b   Cambazard, Frédéric ^b   Pellet, Jacques ^b   Misery, Laurent ^b,c  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^c CHU MORVAN   (France)

Author keywords

Alexithymia; Emotional awareness; Longitudinal study; Psoriasis; Response to treatment; Stress reactivity

Indexed keywords

ADULT; AGED; ALEXITHYMIA; ANXIETY; ARTICLE; AWARENESS; COMORBIDITY; CONSULTATION; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; EMOTION; EMOTIONAL DISORDER; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INFORMATION PROCESSING; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROPSYCHIATRY; PREDICTION; PRIORITY JOURNAL; PSORIASIS; PSYCHIATRIC DIAGNOSIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; STRESS; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; AWARENESS; DERMATOLOGIC AGENTS; EMOTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PSORIASIS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL;

EID: 32944480784     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090653     Document Type: Article

References (58)

1. Koblenzer CS: Psychosomatic concepts in dermatology. Arch Dermatol 1983;119:501-512.
2. Gaston L, Lassonde M, Bernier-Buzzanga J et al: Psoriasis and stress. J Am Acad Dermatol 1987;17:82-86.
3. Farber EM, Rein G, Lanigan SW: Stress and psoriasis. Int J Dermatol 1991;30:8-12.
4. Farber EM, Nall L: Psoriasis: a stress-related disease. Cutis 1993;51:322-326.
5. Al'Abadie MS, Kent GG, Gawkrodger DJ: The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 1994;130:199-203.
6. Ginsburg IH: Psychological and psychophysiological aspects of psoriasis. Dermatol Clin 1995;13:793-804.
7. Panconesi E, Hautmann G: Psychophysiology of stress in dermatology. The psychobiologic pattern of psychosomatics. Dermatol Clin 1996;14:399-421.
8. Suljagic E, Sinanovic O, Tupkovic E et al: Stressful life events and psoriasis during the war in Bosnia. Dermatol Psychosom 2000;1:56-60.
9. Picardi A, Abeni D: Stressful life events and skin diseases: disentangling evidence from myth. Psychother Psychosom 2001;70:118-136.
10. Naldi L, Peli L, Parazzini F et al: Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: results of a case-control study. J Am Acad Dermatol 2001; 44:433-438.
11. Arnetz BB, Fjellner B, Eneroth P et al: Stress and psoriasis: psychoendocrine and metabolic reactions in psoriatic patients during standardized stressor exposure. Psychosom Med 1985; 47:528-541.
12. Schmid-Ott G, Jacobs R, Jager B et al: Stress-induced endocrine and immunological changes in psoriasis patients and healthy controls. A preliminary study. Psychother Psychosom 1998; 67:37-42.
13. Farber EM, Nickoloff BJ, Recht B et al: Stress, symmetry, and psoriasis: possible role of neuropeptides. J Am Acad Dermatol 1986;14: 305-311.
14. Pincelli C, Fantini F, Magrioni C et al: Psoriasis and the nervous system. Acta Derm Venereol Suppl (Stockh) 1994;186:60-61.
15. Misery L: Skin, immunity and the nervous system. Br J Dermatol 1997;137:843-850.
16. Misery L: The neuro-immuno-cutaneous system and ultraviolet radiation. Photodermatol Photoimmunol Photomed 2000;16:78-81.
17. Mazzetti M, Mozzetta A, Soavi GC et al: Psoriasis, stress and psychiatry: psychodynamic characteristics of stressors. Acta Derm Venereol Suppl (Stockh) 1994;186:62-64.
18. Staniek V, Doutremepuich J, Schmitt D et al: Expression of substance P receptors in normal and psoriatic skin. Pathobiology 1999;67:51-54.
19. Weigl BA: Immunoregulatory mechanisms and stress hormones in psoriasis. Int J Dermatol 1998;37:350-357.
20. Niemeier V, Fritz J, Kupfer J et al: Aggressive verbal behaviour as a function of experimentally induced anger in persons with psoriasis. Eur J Dermatol 1999;9:555-558.
21. Fortune DG, Richards HL, Kirby B et al: Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol 2003;139:752-756.
22. Allegranti I, Gon T, Magaton-Rizzi G et al: Prevalence of alexithymic characteristics in psoriatic patients. Acta Derm Venereol 1994; 186:146-147.
23. Sifneos PE: The prevalence of 'alexithymic' characteristics in psychosomatic patients. Psychother Psychosom 1973;22:255-262.
24. Lumley MA, Stettner L, Wehmer F: How are alexithymia and physical illness linked? A review and critique of pathways. J Psychosom Res 1996;41:505-518.
25. Taylor GJ, Bagby RM, Parker JDA: Disorders of Affect Regulation: Alexithymia in Medical and Psychiatric Illness. Cambridge, Cambridge University Press, 1997.
26. Lumley MA, Tomakowsky J, Torosian T: The relationship of alexithymia to subjective and biomedical measures of disease. Psychosomatics 1997;38:497-502.
27. Fortune DG, Richards HL, Griffiths CE, et al: Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol 2002;41:157-174.
28. Hendryx MS, Havilandl MG, et al: Dimensions of alexithymia and their relationships to anxiety and depression. J Pers Assess 1991;56: 227-237.
29. Parker JDA, Bagby RM, et al: Alexithymia and depression: distinct or overlapping constructs? Compr Psychiatry 1991;32:387-394.
30. Wise TN, Mann LS, et al: The stability of alexithymia in depressed patients. Psychopathology 1995;28:173-176.
31. Berthoz S, Consoli S, Perez-Diaz F, et al: Alexithymia and anxiety: compounded relationships? A psychometric study. Eur Psychiatry 1999;14:372-378.
32. Suslow T, Donges US, Kersting A, et al: 20-Item Toronto Alexithymia Scale: do difficulties describing feelings assess proneness to shame instead of difficulties symbolizing emotions? Scand J Psychol 2000;41:329-334.
33. Honkalampi K, Hintikka J, Tanskanen A et al: Depression is strongly associated with alexithymia in the general population. J Psychosom Res 2000;48:99-104.
34. Lane RD, Schwartz GE: Levels of emotional awareness: a cognitive-developmental theory and its application to psychopathology. Am J Psychiatry 1987;144:133-143.
35. Lane RD, Sechrest L, Reidel R, et al: Impaired verbal and nonverbal emotion recognition in alexithymia. Psychosom Med 1996;58:203-210.
36. Schmitt J, Wozel G: The Psoriasis Area and Severity Index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology 2005;210:194-199.
37. Van Der Vleuten CJM, De Jong EMJG, Rulo EHFC, et al: In-patient treatment with calcipotriol versus dithranol in refractory psoriasis. Eur J Dermatol 1995;5:676-679.
38. Ashcroft DM, Wan Po AL, Williams HC, et al: Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol 1999;141:185-191.
39. Sheehan DV, Lecrubier Y, Sheehan KH, et al: The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20):22-33; quiz 4-57.
40. Zigmond AS, Snatith RP: The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370.
41. Taylor G, Bagby R, Ryan D, et al: Criterion validity of the Toronto Alexithymia Scale. Psychosom Med 1988;50:500-509.
42. Loas G, Fremaux D, Marchand MP, et al: L'alexithymie chez le sujet sain: validation de l'échelle d'alexithymie de Toronto (TAS) dans une population 'tout venant' de 144 sujets, application au calcul de la prévalence. Ann Méd Psychol 1993;151:660-663.
43. Bagby RM, Parker JDA, Taylor GJ: The 20-item Toronto Alexithymia Scale. I. Item selection and cross-validation of the factor structure. J Psychosom Res 1994;38:23-32.
44. Bagby RM, Taylor GJ, Parker JDA: The 20-item Toronto Alexithymia Scale. II. Convergent, discriminant, and concurrent validity. J Psychosom Res 1994;38:33-40.
45. Loas G, Fremaux D, Marchand MP: Etude de la structure factorielle et de la cohérence interne de la version française de l'échelle d'alexithymie de Toronto à 20 items (TAS-20) chez un groupe de 183 sujets sains. Encéphale 1995;21:117-122.
46. Lane RD, Quinlan D, Schawartz G, et al: The levels of emotional awareness scale: a cognitive-developmental measure of emotion. J Pers Assess 1990;55:124-134.
47. Bydlowski S, Corcos M, Paterniti S et al: French validation study of the levels of emotional awareness scale. Encéphale 2002;28: 310-320.
48. Hughes JE, Barraclough BM, Hamblin LG, et al: Psychiatric symptoms in dermatology patients. Br J Psychiatry 1983;143:51-54.
49. Gupta MA, Gupta AK, Watteel GN: Early onset (<40 years age) psoriasis is comorbid with greater psychopathology than late onset psoriasis: a study of 137 patients. Acta Derm Venereol 1996;76:464-466.
50. Krueger GG, Koo J, Lewohl M, et al: The impact of psoriasis on quality of life. Arch Dermatol 2001;137:280-284.
51. Fortune DG, Richards HL, Kirby B, et al: A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol 2002;146:458-465.
52. Jula A, Salminen JK, Saarijarvi S: Alexithymia. A facet of essential hypertension. Hypertension 1999;33:1057-1061.
53. Wegrzynek I, Budzanowska E: Alcohol and the skin (in Polish). Przegl Lek 2001;58:198-203.
54. Horne R, Weinamn J: Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychsom Res 1999;6:555-567.
55. Gupta MA, Gupta AK, Kirkby S, et al: A psychocutaneous profile of psoriasis patients who are stress reactors. A study of 127 patients. Gen Hosp Psychiatry 1989;11:166-173.
56. Zachariae R, Zachariae H, Blomqvist K, et al: Self-reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferers. J Eur Acad Dermatol Venereol 2004;18:27-36.
57. Seville RH: Psoriasis and stress. Br J Dermatol 1977;97:297-302.
58. Seville RH: Psoriasis and stress. II. Br J Dermatol 1978;98:151-153.